Improves diagnosis of ALS and Parkinson’s disease

Using SIMCA

An important mission for science today is to develop better diagnostics and better treatments of severe diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Recently, a research group at Umeå University, Sweden, has shed new light on the possibility to improve the diagnosis of ALS and PD and better understand the disease progression.

The results of the study at Umeå University:

Metabolites that differentiate ALS and PD from matched controls and ALS from matched PD, providing additional information, which may lead to earlier diagnosis and guide proper treatment.

Fill out the form to download the Case Story.